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ABSTRACT
The main transcriptional regulator of leucine biosynthesis in the yeast Saccharomyces cerevisiae is the transcription factor
Leu3. It has previously been reported that Leu3 always binds to its target genes, but requires activation to induce their
expression. In a recent large-scale study of high-resolution transcription factor binding site identification, we showed that
Leu3 has divergent binding sites in different cultivation conditions, thereby questioning the results of earlier studies. Here,
we present a follow-up study using chromatin immunoprecipitation followed by sequencing (ChIP-seq) to investigate the
influence of leucine supplementation on Leu3 binding activity and strength. With this new data set we are able to show
that Leu3 exhibits changes in binding activity in response to changing levels of leucine availability.
Keywords: Leu3; transcription factor; ChIP-seq; yeast
INTRODUCTION
In the yeast Saccharomyces cerevisiae, leucine biosynthesis is con-
trolled on a transcriptional level mainly by the interplay of two
transcription factors (TF), the general amino acid metabolism
regulator Gcn4 and one specific for leucine, called Leu3 (Friden
and Schimmel 1987; Kohlhaw 2003). As the three branched-
chain amino acids, leucine, valine and isoleucine, share com-
mon genes in their biosynthetic pathways, Leu3 also influences
valine and isoleucine biosynthesis activity (Kohlhaw 2003).
Leu3 is a TF belonging to the large class of zinc-knuckle
type TFs, which often form homodimers and are depending on
coordinating two zinc ions for binding to the DNA. An interest-
ing feature of Leu3 is its ability to bind alpha-isopropylmalate,
an intermediate of the leucine biosynthetic pathway. It has been
shown that this binding leads to a conformational change and is
necessary for its activation (Hahn and Young 2011). It has been
reported that Leu3 binds to seven genes in the biosynthetic path-
way of leucine starting from pyruvate, namely ILV2, ILV3, ILV5,
LEU1, LEU2, LEU4 and BAT1 (Kohlhaw 2003; MacIsaac et al. 2006).
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The Saccharomyces Genome Database (Cherry et al. 2012) lists
140 known gene targets for Leu3, only 125 of them however are
based on direct evidence from chromatin immunoprecipitation
experiments in multiple S. cerevisiae strains and different condi-
tions.
In earlier publications about Leu3, it has been reported to
always bind to its targets, independent of the leucine availabil-
ity and its activation status (see (Kirkpatrick and Schimmel 1995;
Harbison et al. 2004). In a previous study from our lab, in which
we used high resolution chromatin immunoprecipitation fol-
lowed by exonuclease treatment and sequencing (ChIP-exo), we
observed that Leu3 showed differential binding behavior at four
different cultivation conditions, covering respiratory and fer-
mentative growth (Holland et al. 2019). The four conditions were,
however, so different that it was difficult to assess if this change
in binding behavior was connected to changes in leucine avail-
ability or caused by other effects. Here, we present a follow-up
study with a set of experiments where the only changing vari-
able is the availability of the three branched-chain amino acids,
leucine, valine and isoleucine.
EXPERIMENTAL PROCEDURES
Yeast strains and growth conditions
In this experiment, the S. cerevisiae strain CEN.PK 113–5D (ura3
of CEN.PK113–7D (van Dijken et al. 2000)) with a 9xMyc tag at
the C-terminal end of the Leu3 coding sequence and the URA3
gene from K. marxianus was used as previously described (Hol-
land et al. 2019).
For the experiments, the cells were first grown over night in
shake flasks at 30◦C and 200 rpm shaking in minimal medium
with 2% glucose. The minimal medium consisted of 14.4 g/L
KH2PO4, 0.5 g/L MgSO4, 7.5 g/L (NH4)2SO4, 1 mL/L trace metal
stock solution, 1 mL/L vitamin stock solution. The pH of the
media was adjusted to 6.2–6.3 using KOH pellets. Trace metal
stock solution components (per liter of stock solution) were:
15.0 g EDTA-Na2, 4.5 g CaCl2·2H2O, 4.5 g ZnSO4·7H2O, 3 g
FeSO4·7H2O, 1 g H3BO3, 0.84 g MnCl2·2H2O, 0.4 g Na2MoO4·2H2O,
0.3 g CuSO4·5H2O, 0.3 g CoCl2·6H2O and 0.1 g KI. Vitamin stock
solution components (per liter of stock solution) were: 25 g myo-
inositol, 1 g nicotinic acid, 1 g calcium pantothenate, 1 g pyridox-
ine HCl, 1 g thiamine HCl, 0.2 g 4-aminobenzoic acid and 0.05 g
biotin.
The next day, 10 shake flasks were set up at a starting OD600
of 0.05 in 20 mL of minimal medium with 2 glucose feed beads
(Kuhner Shaker, Herzogenrath, Germany, 12 mm high release
glucose FeedBeads, Art. No. SMFB08001) at 30◦C and 200 rpm
shaking.
After 70 h, the cells were treated with one of the follow-
ing: water as control, low level of leucine (final concentration
20 mg/L), high level of leucine (final concentration 100 mg/L),
high level of isoleucine (final concentration 100 mg/L) or high
level of valine (final concentration 100 mg/L). Each treatment
was performed in duplicates. After an additional 2 h, 50 OD600
of cells were collected for chromatin immunoprecipitation fol-
lowed by sequencing (ChIP-seq) and 5 OD600 of cells were col-
lected for mRNA extraction and qPCR analysis.
Chromatin immunoprecipitation
DNA–protein complexes were cross-linked for 15 min at room
temperature in a 1% formaldehyde solution and the cross-liking




20 mg/l Leucine 1 2
20 mg/l Leucine 2 4
100 mg/l Leucine 1 5
100 mg/l Leucine 2 6
100 mg/l Isoleucine 1 7
100 mg/l Isoleucine 2 8
100 mg/l Valine 1 9
100 mg/l Valine 2 10
reaction was quenched for 5 min at room temperature by addi-
tion of glycine to a final concentration of 125 mM. Finally, the
cells were washed twice with TBS (10 mM Tris-HCl pH 7.5,
150 mM NaCl) and then snap frozen in liquid nitrogen.
The cells were thawed in ice-cold lysis buffer (50 mM
HEPES/KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.1% Na-deoxycholate, 0.05% SDS and 0.2% Sigma P8215
protease inhibitor cocktail) and transferred to MP Biomedicals
Lysing Matrix C glass bead. For cell disruption, the Precellys Fast-
Prep was used with 6 cycles of 25 s and 7400 rpm. The cells were
then transferred to a fresh 5 mL Eppendorf tube and more lysis
buffer was added to a final volume of 3 mL. Using a Branson digi-
tal sonifier 250 with a 1/8-inch microtip, the cells were then soni-
cated for 5 min with pulses of 10 s on and 20 s off at an amplitude
setting of 30%. After sonication, the solution was centrifuged at
21 000 g for 15 min at 4◦C to remove the cell debris.
The immunoprecipitation was done using 15 μL of Pierce
Anti-c-Myc magnetic beads over night at 4◦C. After that the
beads were washed with lysis buffer without protease inhibitor
and SDS, then with IP wash buffer (10 mM Tris-HCl pH 7.5,
250 mM LiCl, 2 mM EDTA, 0.5% Triton X-100 and 0.5% Na-
deoxycholate) and then with 10 mM Tris-HCl pH 8.0 plus 0.025%
Tween20.
After washing, the DNA was eluted from the beads and the
cross linking was reversed using Myc-elution buffer (25 mM Tris-
HCl pH 8.0, 2 mM EDTA, 200 mM NaCl, 0.5% SDS) with 0.66 μg/μL
protease K and 0.083 μg/μL RNase A. The DNA was extracted
using the Promega ProNex size-selective purification system,
using a double selection with first 1 × volume for an upper
length cutoff of 1000 bp and then 2 × volume for a lower cut-
off of 100 bp.
Library preparation for Oxford Nanopore MinION
sequencing
For sequencing, an Oxford Nanopore MinION sequencing device
was used and the library preparation was done using the Oxford
Nanopore PCR Barcoding Kit (SQK-PBK004). The purified and
size selected DNA were first prepared for adapter ligation using
the NEBNext Ultra II End Repair/dA Tailing Module and purified
again using ProNex. The ligation of the Barcode Adapters (BCA)
was done using the NEB Blunt/TA Ligase MasterMix for 15 min
at 25◦C. After another purification using ProNex, the DNA was
amplified with the Barcode Primers (LBW 01–10) for 25 cycles
using Phusion DNA polymerase. The assigned barcodes for each
sample are shown in Table 1.
After a final purification of the DNA using 1.75 × volume for a
lower cutoff of 200 bp, the 10 samples were pooled in equal ratios
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to a total of 100 ng of DNA in 10 μL of 10 mM Tris-HCl pH 8.0 with
50 mM NaCl. Then the Rapid Adapters (RAP) were added and the
Oxford Nanopore flow cell (version R9.4) was primed and loaded.
Finally, the libraries were sequenced using the Oxford Nanopore
MinKNOW software suite using two flow cells after each other
to obtain a total of 5.1 million reads.
Analysis of sequencing data
The raw fast5 sequence data files were basecalled using the
standalone Oxford Nanopore basecaller Guppy (version 3.6.0)
with a quality threshold of 7, direct quality filtering and direct
demultiplexing and barcode trimming.
The obtained fastq reads were then mapped to the
CEN.PK113–7D genome (Salazar et al. 2017) using Bowtie2 (Lang-
mead and Salzberg 2012) with the local read map setting. The
obtained sam files were then subsequently converted into bam
files using samtools (Li et al. 2009). Leu3 binding peaks were
detected using GEM version 3.4 (Guo, Mahony and Gifford 2012),
which was also used to calculate the signal to noise ratios (SNR)
for the peaks based on the combined replicates, as well as to
estimate the local background noise (also performed by GEM).
The ChIP-seq distribution file from GEM was used together with
the following parameters: q-value threshold of 0.001, length of
kmer between 5 and 18, smoothing width of 30 (default value),
minimum number of events of 5 and a maximum read count per
base position of 4 (default value). For each condition both repli-
cate sequencing files were used as inputs for GEM, which uses an
internal normalization approach to combine replicates and out-
puts an averaged final score. The resulting peaks where assigned
to genes based on their distance to the transcription start site
(TSS), obtained from a previous study (Börlin et al. 2019). Peaks
with a distance less than 1000 bp away from a TSS annotation
(independent of upstream of downstream) were assigned to the
corresponding gene. If a peak was close enough to two genes, it
was assigned to both genes.
Measuring mRNA expression levels using qPCR
For mRNA extraction, the cells were disrupted using 500 mg
of acid washed glass beads with a diameter of 425–600 μM on
a Precellys FastPrep for 40 s with 7200 rpm. RNA was subse-
quently extracted using the RNeasy R© Mini Kit from Qiagen,
Hilden, Germany. RNA quality and quantity were assessed using
a ThermoFischer, Waltham, MA, USA, NanoDrop and 2μg of RNA
were reverse transcribed into cDNA using the Qiagen Quanti-
Tect Reverse transcription kit. Expression levels of LEU1 were
measured using the ThermoFisher Dynamo Color Flash SYBR
Green qPCR kit on an Agilent Technologies, Santa Clara, CA, USA,
Stratagene Mx3005p (2 step qPCR protocol, 10 min initialization
at 95◦C, 40 cycles of: 30 s 95◦C, 60 s 60◦C). For control of input
cDNA amounts the levels of LEU1 were normalized using the
Ct method to measured levels of TAF10 (3 step qPCR proto-
col, 10 min initialization at 95◦C, 40 cycles of: 30 s 95◦C, 60 s 56◦C,
30 s 72◦C). The used primers are shown in Table 2. For both qPCR
measurements the samples were analyzed in technical dupli-
cates.
RESULTS AND DISCUSSION
In this study about the condition dependent behavior of the
leucine biosynthesis controlling transcription factor Leu3, we
measured the binding activity of Leu3 in S. cerevisiae using chro-
matin immunoprecipitation followed by sequencing (ChIP-seq).






The only variable changing in these experiments was the addi-
tion of leucine or the two other branched-chain amino acids,
valine and isoleucine to the media. For that, the cells were
treated with either: (i) water as control, (ii) 20 mg/mL leucine, (iii)
100 mg/L leucine, (iv) 100 mg/L valine or (v) 100 mg/L isoleucine.
After the treatment cells were collected for ChIP-seq and mRNA
extraction to validate that the treatment does affect expression
of known binding targets of Leu3. The experimental setup is
summarized in Fig. 1A.
Using qPCR measurements for LEU1 mRNA levels, we
observed that the chosen treatments affected the expression of
LEU1, one of the major genes in the biosynthetic pathway for
leucine. As shown in Fig. 1B, the addition of any of the three
branched-chain amino acids lowered the expression of LEU1,
with leucine and valine having the similar effect with a reduc-
tion to around 40% of the control values. This reduction of LEU1
expression in the presence of leucine has also been reported pre-
viously (Hsu and Schimmel 1984). These changes in expression
validate the treatment strategy allowing us to be confident that
observed changes in Leu3 binding patterns are caused by the
availability of leucine, valine or isoleucine.
The obtained ChIP-seq raw sequencing data from Oxford
Nanopore MinION were base called and demultiplexed and
then mapped to the genome. In total, 5.12 million reads were
sequenced, of which more than 88% passed the quality thresh-
old and had an identifiable barcode sequence. Of these, 944 805
reads (18.4%) could be mapped to the reference genome. An
overview of the respective number of reads is shown in Fig. 2A.
The distribution of read lengths is displayed in Fig. 2B, with an
average read length of 193. One can observe that there is no read
length bias regarding reads that passed the quality threshold or
had an identifiable barcode, but there is a strong bias for longer
reads with regard to mapping to the reference genome. This is
not surprising as mapping a read with sequencing errors to the
genome is easier if the read is longer. Therefore, the average read
length of mapped reads is 271. The number of mapped reads per
sample also varies between 21k and 253k as shown in Fig. 2C.
Starting from the mapped reads, peaks in TF binding were
detected using GEM (Guo, Mahony and Gifford 2012) and only
peaks with a signal-to-noise ratio (SNR) of at least two were
retained. The background noise levels were estimated using
GEM. These peaks were assigned to genes based on the dis-
tance to the transcription start site (TSS). The number of gene
targets in each condition is shown in Fig. 3A and the complete
list of binding targets and the corresponding binding strengths
can be found in Table S1 (Supporting Information). Interestingly,
the control condition was the condition with the highest binding
activity with 106 identified gene targets out of a total of 107. The
only gene that is not bound in the control condition is SOK2 that
is weakly bound with the addition of isoleucine. The addition
of leucine led to a strong reduction in number of gene targets,
with 50 gene targets in the low leucine and 49 in the high leucine
condition. The addition of the two other branched-chain amino
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Figure 1. Experimental setup and validation of treatment effect. (A) Overview of experimental setup used. (B) Measured LEU1 mRNA levels (normalized to TAF10 and
control levels using Ct method) for the four treatment conditions.
Figure 2. Overview of sequencing data. (A) Number of sequenced reads for all conditions combined and how many passed the different filtering steps. (B) Histogram
of the read length of all reads across the conditions and change of the distribution after the different filtering steps. (C) Number of mapped reads per sample (each
sample has its own unique barcode).
acids, valine and isoleucine, resulted in less reduction of bind-
ing (62 and 72 targets for valine and isoleucine respectively). As
Leu3 is mainly a regulator of leucine biosynthesis and not a gen-
eral branched-chain amino acid biosynthesis regulator, it is not
surprising that valine and isoleucine showed less effect. In total
107 genes were bound in at least one of the conditions and their
distribution and overlap across the five conditions is shown in
Fig. 3B. Here, we could observe that less than half of all gene tar-
gets were bound at all five conditions. This binding behavior is
in contrast to earlier literature (Kirkpatrick and Schimmel 1995)
but confirms what we saw before in ChIP-exo data from different
bioreactor cultivations (see (Holland et al. 2019)
We also investigated the spatial distribution of the detected
peaks in relation to the transcription start site (TSS) of their tar-
get genes and the distribution is shown in Fig. 3C. The peaks
were classified as either constant, meaning that they were
bound in all five condition, or as conditional if they showed no
binding in at least one condition. As expected, the majority of
all peaks are 750–100 bp upstream of the TSS with no binding
observed directly around the TSS. There is also no marked dif-
ference in the spatial distribution of the two types of detected
peaks. Using the motif discovery software MEME (Bailey and
Elkan 1994), we observed that there was no significant difference
in the most common motif for peaks that are either classified as
constant or conditional (data not shown).
In the list of 43 gene targets that showed binding in all con-
ditions, most of the leucine biosynthetic genes, like LEU1, LEU2,
LEU4, ILV2, ILV3 and ILV5, are included. This could explain why
previous studies have found that Leu3 always binds to its tar-
gets. The newer technologies used here however allows us not
only to obtain a binary output of binding/no-binding but also
to qualitatively assess the binding strength using the SNR of
the binding. For the aforementioned genes this is displayed in
Fig. 4, together with BAT1, another important gene in leucine
biosynthesis, which was however not bound in the presence
of high amounts of leucine. One can observe that the binding
strength for all seven genes was reduced with the addition of
any of the three branched-chain amino acids and that leucine
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Figure 3. Detected gene targets for Leu3. (A) Number of detected Leu3 binding targets for each of the five conditions. Only peaks detected by GEM with a signal to
noise ratio of ≥ 2 that are within 1000 bp of a TSS were taken into account. (B) Distribution and overlap of the Leu3 gene targets between the five conditions. Venn
diagram made using the python package pyvenn, version 0.1.3, available from PyPI. (C) Distribution of peak distances to the transcription start site (TSS) binned in
50 bp intervals, divided into peaks detected in all five conditions (constant peaks) and peaks that were only detected in some conditions (conditional peaks).
Figure 4. Leu3 binding strength on leucine metabolic genes. Peak binding strength (signal to noise ratio, SNR) normalized to control levels of Leu3 on genes involved
in leucine biosynthesis in the five different conditions used.
had the strongest effect. On average, the addition of leucine to
the media reduced the binding strength by more than 50%. Inter-
estingly, the lower level of leucine seems to have a bigger effect
with a reduction of 60%, than the high level, with a reduction
of only 42%. The high level of leucine still had a stronger effect
than valine and isoleucine, with a reduction of only 33% each.
The overall reduction means that even though these genes are
still bound in the presence of leucine the binding activity of Leu3
is reduced. This can lead to a reduction in gene expression lev-
els, which is exactly what we can observe for the mRNA levels
of LEU1 (see Fig. 1B).
CONCLUSION
Here, we could show that the binding activity of the leucine
biosynthetic TF Leu3 is affected by changing environments and
specifically by changes in the availability of leucine and the
two other branched-chain amino acids, valine and isoleucine.
This is in contrast to earlier molecular studies from the
1990s (Kirkpatrick and Schimmel 1995), but is in line with
our published data using ChIP-exo in another set of four dif-
ferent conditions besides the five tested here (Holland et al.
2019).
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